The person who books an appointment about their antidepressants has usually been taking them for a while. Two years, in one common version. The doctor explained it simply at the time. Low serotonin, a chemical imbalance, and this tablet corrects it. It made sense, she took them, and within about six weeks she felt substantially better.
Then the headlines arrived. A major review saying depression is not caused by a chemical imbalance. She reads three articles about it. A friend forwards a fourth. Somewhere in a comment section a stranger writes that the whole thing is placebo. She has thirty tablets in the kitchen cupboard and no idea any more whether she has been taking medicine or a story. She stops for four days to test it and feels genuinely awful, which frightens her more. And the question she arrives with is always some version of the same one. Was I lied to, and does that mean these do not work?
This blog is for people taking antidepressants, people weighing up whether to start, and anyone who quietly stopped because of something they read online. The honest picture is more interesting than either camp allows, and it does not require choosing between the drugs being magic or being fraud.
Start with the thing everybody was told, because it is the root of most of the confusion.
For decades, patients were given a tidy explanation. Depression is low serotonin. SSRIs raise serotonin. Therefore the tablet fixes the deficiency, in the way insulin addresses diabetes. Clean, mechanical, easy to accept.
In 2022 a systematic umbrella review in Molecular Psychiatry examined the accumulated evidence and concluded there is no consistent support for the idea that depression is caused by low serotonin or reduced serotonin activity. The finding was not new to researchers. It was new to the public, because the simplified version had been repeated in consulting rooms for thirty years.
Here is the part that got lost in the reporting. That review looked at what causes depression. It did not test whether antidepressants work. Those are separate questions, and the coverage collapsed them into one.
A wrong explanation for how something works is not proof that it does not.
This is where the evidence is genuinely nuanced, and you deserve the real version rather than either slogan.
The largest analysis of this was published in the Lancet in 2018, covering 522 double-blind trials and nearly 117,000 patients across 21 different antidepressants. Every single one of the 21 performed better than placebo. That result is solid and has held up.
The argument since has not been about whether there is a difference. It is about the size of it. The average benefit came out at roughly two points on a standard depression rating scale, and some researchers argue the threshold for a clinically meaningful change should be higher than that. Others point out that averages across a hundred thousand people hide enormous individual variation.
That last point matters more than the debate. An average of two points can be made up of a lot of people who felt very little, and a substantial group whose symptoms lifted considerably. The average is not the experience of any actual person.
Antidepressants are not a fraud and they are not a cure. They help a meaningful proportion of people meaningfully, and predicting in advance who that will be remains genuinely difficult.
They lift the floor. Most people who respond describe it in structural terms rather than emotional ones:
They do not manufacture happiness. Nobody takes sertraline and becomes cheerful. They do not fix a job you hate, a marriage that is failing, or grief you have not processed, and they will not do the work therapy does.
For a fair number of people they also do something less discussed, which is flatten the upper range as well as the lower one. Emotional blunting is a real and reported effect, and it is a legitimate reason to talk to a prescriber about dose or switching rather than a reason to endure it silently.
This is the part almost nobody is warned about properly, and it is why a lot of people quit before they get anywhere.
The benefits take time, typically four to six weeks and sometimes longer. The side effects do not. Nausea, headaches, disturbed sleep, restlessness and appetite changes tend to show up in the first fortnight, which means the initial experience is often all cost and no return.
Trials tracking this find that side effect reports reduce over the following weeks for most people. So the two curves cross eventually. The problem is that a lot of people stop during the window where the drug feels like it is only making things worse.
Sexual side effects deserve separate mention because they are common, frequently not raised by prescribers, and unlike nausea they often do not fade. Say it out loud at the appointment. There are usually options.
If you take one practical thing from this article, take this.
Do not stop abruptly, and do not stop without speaking to your prescriber. Withdrawal effects are real, sometimes severe, and were minimised for years before the evidence caught up.
A recent network meta-analysis in Lancet Psychiatry compared stopping strategies in people whose depression had remitted. Slow tapering over more than four weeks, combined with psychological support, worked as well as staying on the medication and clearly better than stopping abruptly or quickly. Tapering with support beat tapering without it, at both speeds.
What those four bad days in the earlier story usually represent is discontinuation effects, not proof the medication was doing nothing. It is easy to read it the other way round.
Medication and therapy are not competing options and treating them as rivals helps nobody. For a large number of people the combination outperforms either alone, and the tapering evidence points the same way, since psychological support improved outcomes even when the drug was being withdrawn.
The other honest point is that the first antidepressant does not always work. If yours has not, that is common and expected rather than a sign that nothing will. Prescribers switch, adjust doses, and combine for exactly this reason.
Antidepressants are neither a chemical correction of a deficiency nor an elaborate placebo, and the argument has been stuck between those two positions for years to nobody's benefit.
What they are is a treatment with real, measurable, moderate effects that works well for some people, partially for others, and not at all for a few, given with an explanation that turned out to be wrong while the medicine itself remained useful.
Stop deciding this from headlines and comment sections. Book a consultation with Zivanza Wellness and have the conversation with someone who can look at your actual situation. Book Now